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ABSTRACT: The interference of glibenclamide, an an-
tidiabetic sulfonylurea, with mitochondrial bioener-
getics was assessed on mitochondrial ion fluxes (H+,
K+, and Cl−) by passive osmotic swelling of rat liver
mitochondria in K-acetate, KNO3, and KCl media,
by O2 consumption, and by mitochondrial transmem-
brane potential (∆ψ). Glibenclamide did not perme-
abilize the inner mitochondrial membrane to H+, but
induced permeabilization to Cl− by opening the in-
ner mitochondrial anion channel (IMAC). Cl− influx
induced by glibenclamide facilitates K+ entry into mi-
tochondria, thus promoting a net Cl−/K+ cotransport,
∆ψ dissipation, and stimulation of state 4 respiration
rate. It was concluded that glibenclamide interferes
with mitochondrial bioenergetics of rat liver by per-
meabilizing the inner mitochondrial membrane to Cl−
and promoting a net Cl−/K+ cotransport inside mi-
tochondria, without significant changes on membrane
permeabilization to H+. C© 2004 Wiley Periodicals, Inc.
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INTRODUCTION
Sulfonylureas, such as glibenclamide, glipizide,
and tolbutamide, are oral hypoglycemics widely used
in the treatment of type 2 diabetes to stimulate insulin
release from pancreatic -cells [1]. Although the molec-
ular mechanism of action of antidiabetic sulfonylureas
is not fully understood, it is believed that the thera-
peutic effect of these drugs results primarily from their
binding to high-affinity receptors (SUR) in the plasma
membrane of pancreatic -cells [2]. The pancreatic -
cell SUR was cloned [1] and identified as an element
composing, together with a K+ pore, the functional
ATP-sensitive K+ (KATP) channel [3]. Binding of sul-
fonylureas to the SUR causes a closure of the KATP
channel, leading to -cell membrane depolarization,
opening of voltage-dependent Ca2+ channels, and, ul-
timately, increase in the exocytosis of insulin [2].
A K+ channel with properties similar to those of
the KATP channel from the plasma membrane of pan-
creatic -cells was described in the inner membrane
of rat liver and beef heart mitochondria, and desig-
nated as the mitochondrial ATP-sensitive K+ channel
(mitoKATP channel) [4,5]. Equilibrium binding stud-
ies using [3H]-labelled glibenclamide revealed a single
class of low-affinity binding sites for glibenclamide in
intact rat liver mitochondria (mitochondrial sulfony-
lurea receptor, mitoSUR) with a Kd of 4 M [6]. In beef
heart mitochondria, the Kd for glibenclamide binding is
much lower: 300 nM [6]. The use of [125H]glibenclamide
led to the identification of the mitSUR as a 28-kDa
polypeptide [7], which may represent part of a more
complex mitoKATP channel. Glibenclamide binding to
mitochondria is modulated by SH reagents such as N-
ethylmaleimide and mersalyl [8].
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The effects of antidiabetic sulfonylureas on
mitoKATP channel have been observed both in intact mi-
tochondria [4,9] and in proteoliposomes reconstituted
with partly purified mitoKATP channel [5,10]. This chan-
nel is blocked by glibenclamide [4,5] after being opened
by Mg2+, ATP, and physiological activators such as GTP,
or the K+ channel opener diazoxide [10]. In such an
induced open state of the mitoKATP channel, gliben-
clamide inhibited the channel activity with a K1/2 value
of 1 to 6 M [10]. In intact mitochondria, the elec-
trogenic transport of potassium (K+ uniport) induced
by Mg2+ depletion is also blocked by glibenclamide
in a concentration-dependent manner, with an IC50 of
20 M [11]. However, a more recent study showed that
50 M glybenclamide induced, by itself, K+ influx in-
side mitochondria [12].
Additionally, glibenclamide interferes with mito-
chondrial bioenergetics, as shown by inhibition of un-
coupled respiration in both liver (IC50 = 70 ± 2 M)
and heart mitochondria (IC50 = 5.3 ± 0.5 M) [10], dis-
sipation of mitochondrial membrane potential and pro-
ton gradient (IC50 = 70 ± 7 M) [13], and lowering of
mitochondrial ATP content in rat liver mitochondria
[14]. However, the mechanism by which glibenclamide
interferes with mitochondrial bioenergetics is not com-
pletely understood. Some investigators reported that
it may be related with the ability of glibenclamide to
increase the proton conductance of the inner mitochon-
drial membrane [13], while others report that it may be
related with K+ influx inside mitochondria [12].
The mitochondrial inner membrane possesses an
anion channel (IMAC) mediating the electrophoretic
transport of a wide variety of anions, and it is believed
to be an important component of the mitochondrial
volume homeostasis mechanism [15,16].
In order to clarify the mechanism by which gliben-
clamide interferes with mitochondrial bioenergetics,
the influence of glibenclamide on mitochondrial ion
fluxes (H+, K+, and Cl−) was assessed by passive os-
motic swelling of rat liver mitochondria in K-acetate,
KNO3, and KCl media, by mitochondrial transmem-
brane potential (ψ), and by O2 consumption in state
4 respiration.
MATERIALS AND METHODS
Animals
Male Wistar rats (250–350 g), housed at 22 ± 2◦C
under artificial light for a 12-h light/dark cycle and with
access to water and food ad libitum, were used through-
out the experiments. The experiments were carried out
in accordance with the National Requirements for Ver-
tebrate Animal Research and European Convention for
the Protection of Animals used for Experimental and
other Scientific Purposes.
Isolation of Rat Liver Mitochondria
Rat liver mitochondria were isolated from male
Wistar rats (6 weeks) by differential centrifugation ac-
cording to conventional methods [17]. The pellet was
gently resuspended in washing medium, at a protein
concentration of about 50 mg/mL. Protein content was
determined by the biuret method [18], using bovine
serum albumin as standard.
Mitochondrial Swelling
Mitochondrial osmotic volume changes were mea-
sured by the apparent absorbance changes at 520 nm
with a suitable spectrophotometer-recorder setup. Mi-
tochondria (1 mg) were suspended in 2.5 mL of the
required medium (K+-acetate, KNO3, or KCl) supple-
mented with 2 M rotenone, at 30◦C. Each medium
contained 55 mM potassium salts, 5 mM HEPES (pH
7.1), and 0.1 mM EDTA.
Measurement of Respiratory Activities
Oxygen consumption was monitored polarograph-
ically at 30◦C with a Clark oxygen electrode, in a closed
chamber with magnetic stirring. The reaction medium
consisted of 250 mM sucrose, 10 mM HEPES (pH 7.2),
20 mM KCl, 5 mM potassium phosphate, and 2 mM
MgCl2. Mitochondria (1 mg protein) were incubated in
1 mL of medium containing 250 mM sucrose, 10 mM
HEPES (pH 7.2), 20 mM KCl, 5 mM potassium phos-
phate, and 2 mM MgCl2, supplemented with 2 M
rotenone and energized with 10 mM succinate. State
4 respiration was achieved after phosphorylation of 50
nmol adenosine diphosphate (ADP). State 4 respiration
rate was calculated considering that the saturation oxy-
gen concentration was 232 nmol O2/mL in the medium
at 30◦C, and the values are expressed in nmol O2 (mg
protein)−1 min−1.
Measurement of Mitochondrial
Transmembrane Potential (ψ)
The mitochondrial transmembrane potential (ψ)
was measured indirectly based on the activity of the
lipophilic cation tetraphenylphosphonium (TPP+) us-
ing a TPP+- selective electrode in combination with an
Ag/AgCl-saturated reference electrode, as previously
described [19]. Mitochondria (1 mg protein) were incu-
bated in 1 mL of medium containing 250 mM sucrose,
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10 mM HEPES (pH 7.2), 20 mM KCl, 5 mM potassium
phosphate, and 2 mM MgCl2, supplemented with 2 M
rotenone and 3 M TPP+and energized with 10 mM
succinate. No correction was made for the “passive”
binding of TPP+ to the mitochondria membranes be-
cause the purpose of the experiments was to show rela-
tive changes in potential rather than absolute values. As
a consequence, we can anticipate some overestimation
for the ψ values. Glibenclamide, and the other com-
pounds added (propranolol, cerebrocrast, nigericin,
and dinithrophenol), did not affect TPP+ binding to mi-
tochondria membranes or the electrode response.
Chemicals
All chemicals were obtained from Sigma Chemical
Company (St Louis, MO, USA) except cerebrocrast
(IOS-1.1212; 2-propoxyethyl ester of 2,6-dimethyl-
4-[2-difluoromethoxyphenyl]-1,4-dihydropyridine-
3,5-dicarboxylic acid), which was synthesized at the
Latvian Institute of Organic Synthesis, 21 Airzkraukles
Street, Riga, LV-1006, Latvia. Cerebrocrast and gliben-
clamide were dissolved in absolute dimethyl sulfoxide
(DMSO). Pure solutions of DMSO were added to
controls at the highest volume of glibenclamide DMSO
solutions used [0.1% (v/v) of the experiments final
volume], having no effects on the measured activities.
RESULTS
Effects of Glibenclamide on Nonrespiring
Mitochondria
The effect of glibenclamide on inner mitochondrial
membrane permeabilization to H+ was evaluated by
swelling of nonrespiring mitochondria suspended in
potassium acetate medium (Figure 1). Protonated ac-
etate can cross the inner mitochondrial membrane and
dissociate to acetate anion and H+ into the mitochon-
drial matrix producing a proton gradient which inhibits
swelling. When valinomycin is present, swelling occurs
if the proton gradient is dissipated by the addition of a
protonophore. Glibenclamide, at concentrations up to
100 M, leads to a very small increase on valinomycin-
dependent mitochondrial swelling, indicating that the
proton conductance of the inner mitochondrial mem-
brane is almost not affected.
The effect of glibenclamide on the inner mitochon-
drial membrane permeabilization to K+ was evaluated
by swelling of nonrespiring mitochondria suspended
in KNO3 medium (Figures 2A and B). Inner mitochon-
drial membrane freely permeabilizes nitrate (NO3−),
but swelling is observed only in conditions of K+ in-
flux. In the absence of valinomycin, mitochondria swell
FIGURE 1. Effect of glibenclamide on permeabilization to H+ by
inner membrane of rat liver mitochondria. Assays were performed
in swelling of K-acetate. Mitochondria (1 mg) suspended in 2.5 mL
of K-acetate medium [54 mM K-acetate, 5 mM HEPES (pH 7.1),
0.1 mM EGTA, and 0.2 mM EDTA] supplemented with 2 M
rotenone were incubated at 30◦C. At the end of 30 s of incuba-
tion, valinomycin (Val) (1 g/mL) was added, followed by 1 M
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) or
glibenclamide (Gli) (50 and 100 M) 30 s later. Data represent typical
recordings of experiments obtained from six different mitochondrial
preparations.
FIGURE 2. Comparative effects of glibenclamide on permeabiliza-
tion to K+ by inner membrane of rat liver mitochondria, as depen-
dent on the presence of the anion nitrate (A) or chloride (B). Swelling
assays were performed in KNO3− and KCl media, respectively. Mi-
tochondria (1 mg) suspended in 2.5 mL of the appropriate medium
[containing 5 mM HEPES (pH 7.1), 0.1 mM EGTA, and 0.2 mM EDTA]
supplemented with 2 M rotenone were incubated at 30◦C. At the end
of 30 s of incubation, valinomycin (Val) (1 g/mL) or glibenclamide
(Gli) (100 M) were added. Control denotes assays in the absence of
additions. Data represent typical recordings of experiments obtained
from six different mitochondrial preparations.
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slowly because of the low permeability of the inner mi-
tochondrial membrane to K+. Maximum swelling was
observed by adding valinomycin to provide a uniport
to K+. Addition of glibenclamide (100 M), instead of
valinomycin, leads to a small increase on swelling, in-
dicating that the K+ conductance of the inner mito-
chondrial membrane is not greatly affected (Figure 2A).
However, if Cl− instead of NO3− is present as the
representative anion, the K+ conductance of the inner
mitochondrial membrane greatly increases, suggesting
that K+ entry is dependent on the presence of Cl−
(Figure 2B).
The effect of glibenclamide on the inner mitochon-
drial membrane permeabilization to Cl− was evaluated
by valinomycin-dependent swelling of nonrespiring
mitochondria suspended in KCl medium (Figure 3).
After addition of valinomycin to provide a uniport for
K+, mitochondria swell slowly because of the low per-
meability of the inner mitochondrial membrane to Cl−
[20,21], as compared with maximum swelling induced
by addition of succinate. Succinate, by promoting mito-
FIGURE 3. Effect of glibenclamide on permeabilization to Cl− by
inner membrane of rat liver mitochondria. Swelling assays were per-
formed in KCl medium. Mitochondria (1 mg) suspended in 2.5 mL
of KCl [54 mM KCl, 5 mM HEPES (pH 7.1), 0.1 mM EGTA, and 0.2
mM EDTA] supplemented with 2 M rotenone were incubated at
30◦C. At the end of 30 s of incubation, valinomycin (Val) (1 g/mL)
was added, followed by 2 mM succinate (Suc) or glibenclamide (Gli)
(25, 50, and 100 M) 30 s later. The traces are typical recordings of
experiments obtained from six different mitochondrial preparations.
chondrial respiration, induces mitochondrial matrix al-
kalinization and IMAC opening, thus permitting maxi-
mal permeabilization to Cl−. Addition of glibenclamide
(25, 50, and 100 M), instead of succinate, induced
a significant increase on mitochondrial swelling in a
concentration-dependent manner. These findings indi-
cate that glibenclamide promotes the Cl− influx into the
mitochondrial matrix, probably by opening IMAC.
Transport of Cl− into mitochondria can be elec-
troneutral (Cl−/OH− exchange) or electrogenic (Cl−
uniport) via the inner mitochondrial anion channel
(IMAC) [20]. To discern between these two possibil-
ities, the effect of glibenclamide on the swelling of
nonrespiring mitochondria suspended in KCl medium
was compared with that of tributyltin (TBT), a
well-known Cl−/OH− exchanger [21–23] (Figure 4).
Nigericin was used to provide K+/H+ antiport, fa-
voring TBT action, while propranolol and cerebrocrast
were used as inhibitors of the Cl− entry into mitochon-
drial matrix via IMAC [15,24]. In the absence of vali-
nomycin, glibenclamide (100 M) and TBT (100 nM)
increased the swelling of nonrespiring mitochondria
in KCl medium (Figure 4A). Under these conditions,
nigericin (1 M) stimulated the swelling induced by
TBT, but it inhibited the swelling induced by gliben-
clamide (Figure 4A). In the presence of valinomycin,
glibenclamide (100 M) and TBT (100 nM) also in-
creased the swelling of nonrespiring mitochondria in
KCl medium (Figure 4B). Under these conditions, the
swelling induced by TBT was not affected by pro-
pranolol (200 M) and slightly inhibited by cerebro-
crast (25 M), while the swelling induced by gliben-
clamide was strongly inhibited by both propranol and
cerebrocrast (Figure 4B). Controls in the presence of
propranolol (200 M) and cerebrocrast (25 M) were
also performed. Their traces overlap the control trace,
and they are not represented in Figure 4B. In contrast
to TBT, which promotes Cl− entry by Cl−/OH− ex-
change across the inner mitochondrial membrane, these
findings indicated that the Cl− transport promoted by
glibenclamide is mainly via IMAC.
Effects of Glibenclamide on
Succinate-Respiring Mitochondria
As mitochondria are respiring in normal physi-
ological conditions, the effects of glibenclamide de-
scribed above for nonrespiring mitochondria were also
evaluted by valinomycin-induced volume changes of
succinate-respiring mitochondria in KCl medium (Fig-
ure 5), and  detection in association with O2 con-
sumption (Figure 6).
Figure 5 (A and B) shows that addition of vali-
nomycin to succinate-respiring mitochondria causes a
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FIGURE 4. Comparative effects of glibenclamide and tributyltin (TBT) on permeabilization to Cl− by inner membrane of rat liver mitochondria.
(A), swelling recordings of glibenclamide and TBT in the presence and absence of nigericin; (B), swelling recordings to compare propranolol
and cerebrocrast actions on the effects of Cl− permeabilization induced by TBT and glibenclamide. Swelling assays were performed in KCl
medium. Mitochondria (1 mg) suspended in 2.5 mL of KCl [54 mM KCl, 5 mM HEPES (pH 7.1), 0.1 mM EGTA, and 0.2 mM EDTA] supplemented
with 2 M rotenone were incubated at 30◦C. The additions were performed as indicated in the recordings. Nig, TBT, Gli, Val, Propra and Cer
denote nigericin (1 M), tributyltin (100 nM), glibenclamide (100 M), valinomycin (1 g/mL), propranolol (200 M), and cerebrocrast (25 M),
respectively. Control denotes swelling in the presence of valinomycin alone. The traces are typical recordings of experiments obtained from six
different mitochondrial preparations.
rapid swelling followed by contraction. The swelling
phase reflects passive electrophoretic uniport of K+,
and Cl− entry inside mitochondria, while the contrac-
tion phase reflects the efflux of internal K+ in exchange
for external protons (K+/H+ exchange) driven by the
pH gradient generated by the respiratory chain H+
pumping [15]. Addition of glibenclamide, at concen-
trations up to 100 M, did not affect the initial rate of
swelling, but increased its amplitude (Figure 5A). Addi-
tion of dinitrophenol (DNP), instead of glibenclamide,
decreased the initial rate of swelling, without signifi-
cant effect on its amplitude (Figure 5B). DNP also in-
hibited the rate and amplitude of mitochondrial con-
traction. The data indicated that, in contrast with DNP,
glibenclamide did not affect Cl− influx promoted by
respiration of rat liver mitochondria. However, 100 M
inhibited the K+/H+ exchange, like DNP. The effects of
DNP are related with its ability to dissipate the pH
component of the electrochemical proton gradient, as a
consequence of its protonophoric action. Hence, gliben-
clamide, at concentrations up to 100 M, has no signif-
icant protonophoric action on respiring mitochondria.
The effects of glibenclamide on mitochondrial 
and respiration, developed by mitochondria upon suc-
cinate oxidation, are shown in Figure 6. After succi-
nate addition, mitochondria develop a  of about
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FIGURE 5. Comparative effects of glibenclamide (A) and dinitro-
phenol (DNP) (B) on permeabilization to Cl− by inner membrane
of rat liver mitochondria. Swelling assays were performed in KCl
medium. Mitochondria (1 mg) suspended in 2.5 mL of KCl medium
[54 mM KCl, 5 mM HEPES (pH 7.1), 0.1 mM EGTA, and 0.2 mM
EDTA] supplemented with 2 M rotenone were incubated for 1 min
at 30◦C, and energized by addition of 2 mM succinate. Glibenclamide
(10, 25, 50, and 100 M) or DNP (5, 10 and 20 M) was added 30 s after
energization, followed by valinomycin 30 s later. Suc denotes succi-
nate; Gli, glibenclamide; Val, valinomycin (1 g/mL); DNP, dinitro-
phenol; and −Val, assays in the absence of valinomycin. Data rep-
resent typical recordings of experiments obtained from six different
mitochondrial preparations.
FIGURE 6. Effects of glibenclamide on mitotochondrial transmem-
brane potential (ψ) (A) and state 4 respiration (B) of rat liver mi-
tochondria. Assays were performed with mitochondria (1 mg) in-
cubated, for 1 min at 30◦C, in 1 mL of medium containing 250 mM
sucrose, 10 mM HEPES (pH 7.2), 20 mM KCl, 5 mM potassium phos-
phate, and 2 mM MgCl2, supplemented with 2 M rotenone and
3 M TPP+, and energized with 10 mM succinate (Suc). State 4 res-
piration was reached after phosphorylation of 50 nmol adenosine
diphosphate (ADP) (not represented in the records). Glibenclamide
(Gli) 100 M was added to mitochondria respiring in state 4. Values
indicated are in nmol O2 (mg protein)−1 min−1. The traces are typical
recordings of experiments obtained from six different mitochondrial
preparations.
−224 mV (negative inside). The respiratory rate of state
4 was 15 nmol O2 (mg protein)−1 min−1. Addition of
glibenclamide (100 M) depressed  to −213 mV,
increasing state 4 respiration rate to 28 nmol O2 (mg
protein)−1 min−1, thus indicating that glibenclamide in-
terferes with mitochondrial bioenergetics. These effects
of glibenclamide are compatible with permeabilization
of the inner mitochondrial membrane to cations such as
H+ or K+, but the results presented in this study favor
permeabilization to K+ (Figures 2 and 3), rather than to
H+ (Figures 1 and 5).
DISCUSSION
The results presented in this study clearly showed
that glibenclamide has no significant effect on in-
ner mitochondrial membrane permeabilization to H+
(Figure 1), permeabilizing it to Cl−, in a concentration-
dependent manner (Figure 3). Permeabilization to K+
was dependent on Cl− influx induced by glibenclamide
(Figures 2 and 3), thus promoting a net Cl−/K+ co-
transport (Figure 3), ψ dissipation, and stimulation
of state 4 respiration rate in rat liver mitochondria
(Figure 6).
Glibenclamide-induced membrane permeabiliza-
tion to Cl− was inhibited by specific inhibitors of
IMAC, namely propranolol and cerebrocrast [15,24]
(Figure 4B). It was also inhibited in the presence of
nigericin, an exogenous K+/H+ antiporter, which fa-
vors the Cl−/OH− exchange by tributyltin (Figure 4A).
The data suggested that Cl− influx induced by gliben-
clamide in rat liver mitochondria is mainly via IMAC
rather than Cl−/OH− exchange. Permeabilization of
anions by IMAC only occurs under low Mg2+ con-
centrations and/or alkaline matrix conditions [15]. The
possibility of glibenclamide to induce IMAC opening
by depletion of matrix Mg2+ by exchange with H+, like
A23187 [15], is excluded, because glibenclamide, in con-
trast with A23187, did not increase the transmembrane
potential () of succinate-respiring mitochondria in a
free-Mg2+ reaction medium (results not shown). IMAC
opening by glibenclamide may be related with its abil-
ity to induce mitochondrial matrix alkalinization [12].
This is the first study presenting evidence that gliben-
clamide permeabilizes the inner mitochondrial mem-
brane to Cl− by opening IMAC. However, activation of
Cl− channels by glibenclamide in the membrane of in-
sulin secretory granules of pancreatic  cells has been
reported [24–28].
Comparison of the effects of glibenclamide on the
swelling of nonrespiring mitochondria in KCl and
KNO3 media showed that glibenclamide stimulates
swelling in KCl to a greater extent than in KNO3
medium (Figures 2 and 3), indicating that membrane
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permeabilizion to K+ by glibenclamide is dependent
on the presence of Cl−, thus promoting a net Cl−/K+
cotransport inside rat liver mitochondria.
Valinomycin-induced swelling of succinate-
respiring mitochondria in KCl shows that, in contrast
with DNP, glibenclamide did not affect the initial rate
of swelling, but increased its amplitude (Figure 5),
thus confirming that glibenclamide has no significant
protonophoric action (Figure 1). Therefore, the 
dissipation and stimulation of state 4 respiration
rate induced by glibenclamide (Figure 6) [13,14] may
be related with its ability to permeabilize the inner
mitochondrial membrane to K+ and to promote a net
Cl−/K+ cotransport inside mitochondria rather than
with a protonophoric action.
In summary, glibenclamide interferes with mito-
chondrial bioenergetics of rat liver by permeabilizing
the inner mitochondrial membrane to Cl− and pro-
moting a net Cl−/K+ cotransport inside mitochondria,
without significant changes on membrane permeabi-
lization to H+.
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